[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SG144914A1 - A method for the preparation of enantiomerically pure mirtazapine - Google Patents

A method for the preparation of enantiomerically pure mirtazapine

Info

Publication number
SG144914A1
SG144914A1 SG200805127-8A SG2008051278A SG144914A1 SG 144914 A1 SG144914 A1 SG 144914A1 SG 2008051278 A SG2008051278 A SG 2008051278A SG 144914 A1 SG144914 A1 SG 144914A1
Authority
SG
Singapore
Prior art keywords
preparation
enantiomerically pure
pure mirtazapine
mirtazapine
enantiomerically
Prior art date
Application number
SG200805127-8A
Other languages
English (en)
Inventor
Johannes Hubertus Wieringa
De Ven Adrianus Antonius M Van
Gerardus Johannes Kemperman
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of SG144914A1 publication Critical patent/SG144914A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG200805127-8A 2003-07-10 2004-07-05 A method for the preparation of enantiomerically pure mirtazapine SG144914A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03102095 2003-07-10

Publications (1)

Publication Number Publication Date
SG144914A1 true SG144914A1 (en) 2008-08-28

Family

ID=34042934

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200805127-8A SG144914A1 (en) 2003-07-10 2004-07-05 A method for the preparation of enantiomerically pure mirtazapine

Country Status (36)

Country Link
US (2) US8058436B2 (pl)
EP (1) EP1656365B1 (pl)
JP (1) JP4668184B2 (pl)
KR (1) KR20060056315A (pl)
CN (1) CN100558722C (pl)
AR (1) AR046494A1 (pl)
AT (1) ATE433965T1 (pl)
AU (1) AU2004255874B2 (pl)
BR (1) BRPI0412447A (pl)
CA (1) CA2531165C (pl)
CO (1) CO5640123A2 (pl)
CY (1) CY1109327T1 (pl)
DE (1) DE602004021605D1 (pl)
DK (1) DK1656365T3 (pl)
EC (1) ECSP066271A (pl)
ES (1) ES2327123T3 (pl)
HK (1) HK1086841A1 (pl)
HR (1) HRP20051019A2 (pl)
IL (1) IL172549A0 (pl)
IS (1) IS2674B (pl)
LT (1) LT5382B (pl)
LV (1) LV13441B (pl)
MX (1) MXPA06000325A (pl)
NO (1) NO20056175L (pl)
NZ (1) NZ544360A (pl)
PE (1) PE20050323A1 (pl)
PL (1) PL1656365T3 (pl)
PT (1) PT1656365E (pl)
RS (1) RS20050972A (pl)
RU (1) RU2352566C2 (pl)
SG (1) SG144914A1 (pl)
SI (1) SI1656365T1 (pl)
TW (1) TWI335915B (pl)
UA (1) UA83666C2 (pl)
WO (1) WO2005005410A1 (pl)
ZA (1) ZA200600019B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5080050B2 (ja) * 2005-09-26 2012-11-21 住友化学株式会社 光学活性なピペラジン化合物の製造方法
CN102126982A (zh) * 2005-09-26 2011-07-20 住友化学株式会社 光学活性的哌嗪化合物的制造方法
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
TW200815370A (en) * 2006-06-16 2008-04-01 Organon Nv Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine
JP5438976B2 (ja) * 2007-02-09 2014-03-12 株式会社カネカ 光学活性２−アリールピペラジン誘導体の製造法
JP5192707B2 (ja) * 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
US7994314B2 (en) 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
AR066005A1 (es) * 2007-04-11 2009-07-15 Organon Nv Un metodo para la preparacion de un enantiomero de una benzazepina tetraciclica
KR101485418B1 (ko) * 2013-05-29 2015-01-26 주식회사 메디켐코리아 고순도 미르타자핀의 제조방법
RS62055B1 (sr) 2015-02-27 2021-07-30 Dechra Ltd Stimulacija apetita, upravljanje gubitkom težine i lečenje anoreksije kod pasa i mačaka
KR102540021B1 (ko) * 2020-12-02 2023-06-07 (주)유케이케미팜 대량 생산에 적합한 미르타자핀의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959470A (en) * 1972-11-28 1976-05-25 Mikhail Davidovich Mashkovsky Psychotropic medicinal preparation
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
IE903557A1 (en) * 1989-10-05 1991-04-10 Sankyo Co Novel tetracyclic compounds having anti-allergic and¹anti-asthmatic activities, their preparation and use
JPH11222407A (ja) * 1997-11-14 1999-08-17 Sankyo Co Ltd 新規殺菌剤
CN1154495C (zh) 1997-11-14 2004-06-23 阿克佐诺贝尔公司 米氮平用于治疗睡眠性呼吸暂停的用途
RU2001128229A (ru) * 1999-04-19 2003-07-10 Тева Фармасьютикал Индастриз Лтд. (Il) Новый синтез и кристаллизация соединений, содержащих пиперазиновое кольцо
US20030069417A1 (en) * 1999-04-19 2003-04-10 Claude Singer Novel synthesis and crystallization of piperazine ring-containing compounds
US6068695A (en) * 1999-07-13 2000-05-30 Bayer Corporation Process for the continuous preparation of quinacridones
AU6476300A (en) 1999-09-30 2001-05-10 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a piperazine derivative
AU6474200A (en) 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
RU2270680C2 (ru) 2000-02-11 2006-02-27 Акцо Нобель Н.В. Применение миртазапина для лечения расстройств сна
JP2001342188A (ja) * 2000-03-27 2001-12-11 Takeda Chem Ind Ltd 縮合ピラゾール誘導体、その製造法および用途
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts

Also Published As

Publication number Publication date
US8058436B2 (en) 2011-11-15
LT5382B (lt) 2006-11-27
HRP20051019A2 (en) 2006-02-28
AU2004255874B2 (en) 2010-10-28
BRPI0412447A (pt) 2006-09-19
WO2005005410A1 (en) 2005-01-20
DE602004021605D1 (de) 2009-07-30
IL172549A0 (en) 2006-04-10
IS2674B (is) 2010-09-15
LT2005107A (en) 2006-06-27
JP4668184B2 (ja) 2011-04-13
MXPA06000325A (es) 2006-03-30
NZ544360A (en) 2008-05-30
NO20056175L (no) 2006-01-23
TW200510426A (en) 2005-03-16
UA83666C2 (ru) 2008-08-11
ES2327123T3 (es) 2009-10-26
IS8184A (is) 2005-12-15
JP2009513537A (ja) 2009-04-02
LV13441B (en) 2006-08-20
AR046494A1 (es) 2005-12-14
ATE433965T1 (de) 2009-07-15
PT1656365E (pt) 2009-09-01
CY1109327T1 (el) 2014-07-02
PL1656365T3 (pl) 2009-10-30
RS20050972A (en) 2008-06-05
ECSP066271A (es) 2006-07-28
HK1086841A1 (en) 2006-09-29
RU2352566C2 (ru) 2009-04-20
EP1656365A1 (en) 2006-05-17
CO5640123A2 (es) 2006-05-31
ZA200600019B (en) 2007-01-31
US20100179319A1 (en) 2010-07-15
DK1656365T3 (da) 2009-09-14
TWI335915B (en) 2011-01-11
PE20050323A1 (es) 2005-05-16
KR20060056315A (ko) 2006-05-24
RU2006103992A (ru) 2006-06-27
SI1656365T1 (sl) 2009-10-31
CA2531165A1 (en) 2005-01-20
EP1656365B1 (en) 2009-06-17
AU2004255874A1 (en) 2005-01-20
CN1820000A (zh) 2006-08-16
CN100558722C (zh) 2009-11-11
US20060229300A1 (en) 2006-10-12
CA2531165C (en) 2011-08-30

Similar Documents

Publication Publication Date Title
SG145694A1 (en) Novel compounds
HK1086841A1 (en) A method for the preparation of enantiomerically pure mirtazapine
IL174951A0 (en) Method for the production of amino crotonyl compounds
AU150501S (en) A toothbrush
GB2432609A (en) Method of expansion
GB0304799D0 (en) Novel method
GB0207724D0 (en) Patent submission-Ruthenium as non-magnetic sedlayer for electrodeposition
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
PL1697390T3 (pl) Sposób wytwarzania organoacylofosforynów
AU2003294647A8 (en) Method for producing hydrogen
HK1096398A1 (en) Method for the manufacture of thip thip
SG148154A1 (en) Benzannelated compounds as ppar activators
EP1632478A4 (en) PROCESS FOR PRODUCING PURIFIED 2-CYANOACRYLATE
EP1666442A4 (en) PROCESS FOR PRODUCING CUMENE
HK1133870A1 (en) Method for producing 4-pentafluoride-sulfanyl-benzoylguanidines
EP1619167A4 (en) PROCESS FOR PREPARING DISODIUM PARAPERIODATE
IL174980A0 (en) Process for the preparation of a trifluoromethylthioether
GEU20041064U (en) Method for production of Matsoni
AU2003267340A1 (en) Method for the production of polyetherols
AU2003286309A1 (en) Method for producing pure disodium pamidronate
GB0320966D0 (en) Method for producing hydrogen
PL359045A1 (pl) Sposób wytwarzania benzenosulfonianu amlodypiny
PL362261A1 (pl) Sposób wytwarzania sulfonów trichlorowcometylowoarylowych
PL362957A1 (pl) Sposób wytwarzania bio-membran
HU0302596D0 (en) Procedure for making dirt-walls